Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)

USD 998.89

(0.0%)

Eps Summary of Bristol-Myers Squibb Company PFD CONV 2

  • Bristol-Myers Squibb Company PFD CONV 2's latest annual eps in 2023 was 3.88 USD , up 30.64% from previous year.
  • Bristol-Myers Squibb Company PFD CONV 2's latest quarterly eps in 2024 Q3 was 0.60 USD , down -27.71% from previous quarter.
  • Bristol-Myers Squibb Company PFD CONV 2 reported an annual eps of 2.97 USD in 2022, down -5.71% from previous year.
  • Bristol-Myers Squibb Company PFD CONV 2 reported an annual eps of 3.15 USD in 2021, up 179.15% from previous year.
  • Bristol-Myers Squibb Company PFD CONV 2 reported a quarterly eps of 0.83 USD for 2024 Q2, up 114.09% from previous quarter.
  • Bristol-Myers Squibb Company PFD CONV 2 reported a quarterly eps of -5.89 USD for 2024 Q1, down -777.01% from previous quarter.

Annual Eps Chart of Bristol-Myers Squibb Company PFD CONV 2 (2023 - 1989)

Historical Annual Eps of Bristol-Myers Squibb Company PFD CONV 2 (2023 - 1989)

Year Eps Eps Growth
2023 3.88 USD 30.64%
2022 2.97 USD -5.71%
2021 3.15 USD 179.15%
2020 -3.98 USD -297.03%
2019 2.02 USD -33.33%
2018 3.03 USD 396.72%
2017 0.61 USD -77.57%
2016 2.72 USD 186.32%
2015 0.95 USD -22.13%
2014 1.22 USD -21.79%
2013 1.56 USD 30.0%
2012 1.20 USD -46.9%
2011 2.26 USD 19.58%
2010 1.89 USD -70.79%
2009 6.47 USD 102.19%
2008 3.20 USD 142.42%
2007 1.32 USD 36.08%
2006 0.97 USD -46.99%
2005 1.83 USD 25.34%
2004 1.46 USD -22.75%
2003 1.89 USD 50.0%
2002 1.26 USD -60.63%
2001 3.20 USD 11.5%
2000 2.87 USD 12.99%
1999 2.54 USD 32.29%
1998 1.92 USD -1.54%
1997 1.95 USD 12.07%
1996 1.74 USD 58.18%
1995 1.10 USD -1.79%
1994 1.12 USD -5.88%
1993 1.19 USD -0.83%
1992 1.20 USD -4.0%
1991 1.25 USD 16.82%
1990 1.07 USD 132.61%
1989 0.46 USD -39.47%

Peer Eps Comparison of Bristol-Myers Squibb Company PFD CONV 2

Name Eps Eps Difference
AstraZeneca PLC 3.84 USD -1.042%
CSPC Pharmaceutical Group Limited 0.07 USD -5442.857%
Clarus Therapeutics Holdings, Inc. -8.04 USD 148.259%
Novartis AG 7.63 USD 49.148%
PT Kalbe Farma Tbk. 0.00 USD -99387.179%